Neurotherapeutic Strategies for Multiple Sclerosis.

@article{Frohman2016NeurotherapeuticSF,
  title={Neurotherapeutic Strategies for Multiple Sclerosis.},
  author={Teresa C. Frohman and Shin Chien Beh and Eric J. Kildebeck and Ram Narendra Narayan and Katherine Treadaway and Michael Karl Racke},
  journal={Neurologic clinics},
  year={2016},
  volume={34 3},
  pages={
          483-523
        }
}
Multiple sclerosis (MS) is the most common disabling neurologic disease of young adults. There are now 16 US Food and Drug Administration (FDA)-approved disease-modifying therapies for MS as well as a cohort of other agents commonly used in practice when conventional therapies prove inadequate. This article discusses approved FDA therapies as well as commonly used practice-based therapies for MS, as well as those therapies that can be used in patients attempting to become pregnant, or in… CONTINUE READING
BETA
2
Twitter Mentions

Similar Papers